[{"address1": "80 Guest Street", "address2": "Suite 601", "city": "Boston", "state": "MA", "zip": "02135", "country": "United States", "phone": "617 500 8099", "website": "https://www.compasstherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A (VEGF-A) signaling pathways, which are critical to angiogenesis and tumor vascularization; CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and PD-L1 checkpoint inhibitor antibodies. It also develops CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A, as well as VEGF-IO Bispecific / Multiple, a bispecific antibody engages angiogenesis pathway and anti-tumor immune that targets immune checkpoints and analyzes VEGF combinations with other immune response-related proteins. Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 35, "companyOfficers": [{"maxAge": 1, "name": "Dr. Thomas J. Schuetz M.D., Ph.D.", "age": 63, "title": "Chief Executive Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 835875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Vered  Bisker-Leib MBA, Ph.D.", "age": 53, "title": "Advisor", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 719000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Barry  Shin J.D.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan  Anderman J.D.", "title": "Senior Vice President, General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anna  Gifford", "title": "Communications Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Minori  Rosales M.D., Ph.D.", "age": 61, "title": "Senior VP & Head of Clinical Development", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karin  Herrera B.A.", "title": "Senior VP & Head of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Kranz Ph.D.", "title": "VP and Head of Chemistry Manufacturing & Controls", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.65, "open": 1.63, "dayLow": 1.61, "dayHigh": 1.7, "regularMarketPreviousClose": 1.65, "regularMarketOpen": 1.63, "regularMarketDayLow": 1.61, "regularMarketDayHigh": 1.7, "payoutRatio": 0.0, "beta": 1.187, "forwardPE": -3.3235295, "volume": 650759, "regularMarketVolume": 650759, "averageVolume": 1768423, "averageVolume10days": 4713610, "averageDailyVolume10Day": 4713610, "bid": 1.64, "ask": 1.74, "bidSize": 1, "askSize": 3, "marketCap": 234388000, "fiftyTwoWeekLow": 0.765, "fiftyTwoWeekHigh": 4.08, "priceToSalesTrailing12Months": 275.75058, "fiftyDayAverage": 2.6113, "twoHundredDayAverage": 1.820515, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 81804448, "profitMargins": 0.0, "floatShares": 83626341, "sharesOutstanding": 138282000, "sharesShort": 4607296, "sharesShortPriorMonth": 3534626, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.033299997, "heldPercentInsiders": 0.18077, "heldPercentInstitutions": 0.70961, "shortRatio": 5.43, "shortPercentOfFloat": 0.047, "impliedSharesOutstanding": 138282000, "bookValue": 0.909, "priceToBook": 1.8646866, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -49375000, "trailingEps": -0.36, "forwardEps": -0.51, "enterpriseToRevenue": 96.241, "enterpriseToEbitda": -1.46, "52WeekChange": 0.07278478, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 1.695, "targetHighPrice": 32.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.1, "targetMedianPrice": 10.5, "recommendationMean": 1.3, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 126722000, "totalCashPerShare": 0.916, "ebitda": -56036000, "totalDebt": 6634000, "quickRatio": 14.28, "currentRatio": 14.96, "totalRevenue": 850000, "debtToEquity": 5.297, "revenuePerShare": 0.006, "returnOnAssets": -0.23809999, "returnOnEquity": -0.3607, "grossProfits": 850000, "freeCashflow": -27798624, "operatingCashflow": -44855000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -66.61765, "financialCurrency": "USD", "symbol": "CMPX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Compass Therapeutics, Inc.", "longName": "Compass Therapeutics, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1744411402, "regularMarketTime": 1744401601, "exchange": "NCM", "messageBoardId": "finmb_266166780", "market": "us_market", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "regularMarketChangePercent": 2.7272773, "regularMarketPrice": 1.695, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1768423, "fiftyTwoWeekLowChange": 0.93000007, "fiftyTwoWeekLowChangePercent": 1.2156864, "fiftyTwoWeekRange": "0.765 - 4.08", "fiftyTwoWeekHighChange": -2.3849998, "fiftyTwoWeekHighChangePercent": -0.5845588, "fiftyTwoWeekChangePercent": 7.278478, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747485000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.36, "epsForward": -0.51, "epsCurrentYear": -0.46667, "priceEpsCurrentYear": -3.632117, "fiftyDayAverageChange": -0.91629994, "fiftyDayAverageChangePercent": -0.350898, "twoHundredDayAverageChange": -0.12551498, "twoHundredDayAverageChangePercent": -0.06894477, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-02", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1617629400000, "postMarketChangePercent": -0.884962, "postMarketPrice": 1.68, "postMarketChange": -0.0150001, "regularMarketChange": 0.045000076, "regularMarketDayRange": "1.61 - 1.7", "displayName": "Compass Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]